Event page banner


Upcoming events 



NICE webinar 29 Feb

THURS 29 FEB 2024 1.00PM

Executive MSc Healthcare Decision-Making Information Session (February)

We are holding the first information session of the year for Executive MSc Healthcare Decision-Making for those interested in learning more about the programme.

Application is now open to join from December 2024 and study alongside full-time work.

This unique programme is developed in collaboration with the National Institute for Health and Care Excellence, with a tailored offering of skill-oriented and policy-based courses that will enable a strategic view of healthcare systems required to transition into a senior leadership role.

Participants will be joined by programme co-director, Rocco Friebel, and Head of International Affairs – NICE, Meindert Boysen PharmD MSc. There will also be opportunities to discuss the programme structure, how to apply, and other questions you might have.

Register to attend this session from here. 




TUE 21 NOV 2023 1.00 PM

Master's Study in Health Policy at LSE

LSE's Department of Health Policy will be holding a live online event for prospective master's students. The event will enable prospective students to find out more about the master's study opportunities offered by the department, followed by the opportunity for attendees to submit their own questions. 

The event will take place online via Zoom.

Register to attend this session from here. 




Nov 7, 2023 1:00PM

Seminar Title: Pharmaceutical Pricing, and R&D as a Global Public Good

Bio: William S. Comanor is Distinguished Research Professor in the Department of Health Policy and Management at the UCLA Fielding School of Public Health. He is also Professor of Economics, Emeritus at the University of California, Santa Barbara At UCLA, he serves as Director of the UCLA Research Program in Pharmaceutical Economics and Policy, and founded a long-standing research seminar on pharmaceutical economics. He continues to study, lecture, publish and consult on many issues dealing with pharmaceutical economics. Dr. Comanor received his Ph.D. in economics from Harvard University and was a post-doctoral fellow at the London School of Economics. Prior to joining the faculty of the University of California, he was on the faculties of both Harvard and Stanford Universities. He has authored and edited 6 books and more than 100 professional articles in economics. Dr. Comanor was designated a Distinguished Fellow of the Industrial Organization Society in 2003.


Abstract: In his Labor Day address, President Biden stated that the U.S. “has the highest drug prices in the world, and there is no reason for it.” For new branded drugs, the first part of that statement is supported by a recent RAND Report (2021) which found U.S. average prices are 2.3 times those present in both the 32 OECD countries overall and in the UK separately. In this research, we consider the second part of that statement, and identify the economic factors that suggest a “reason for it."


In-Person: COW 1.11 - Lunch at 12:30 Seminar at 1:00PM 

Online: Zoom Link Here






Don't miss any of our events. Sign up to our mailing list now

Newsletter sign-up 747-420

Check back later for our latest Twitter updates.